Document Detail

The homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failure.
MedLine Citation:
PMID:  22427939     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: CCL19 and CCL21, acting through CCR7, are termed homeostatic chemokines. Based on their role in concerting immunological responses and their proposed involvement in tissue remodeling, we hypothesized that these chemokines could play a pathogenic role in heart failure (HF).
METHODOLOGY/PRINCIPAL FINDINGS: Our main findings were: (i) Serum levels of CCL19 and particularly CCL21 were markedly raised in patients with chronic HF (n = 150) as compared with healthy controls (n = 20). A CCL21 level above median was independently associated with all-cause mortality. (ii) In patients with HF following acute myocardial infarction (MI; n = 232), high versus low CCL21 levels 1 month post-MI were associated with cardiovascular mortality, even after adjustment for established risk factors. (iii). Explanted failing human LV tissue (n = 29) had markedly increased expression of CCL21 as compared with non-failing myocardium (n = 5). (iv) Our studies in CCR7(-/-) mice showed improved survival and attenuated increase in markers of myocardial dysfunction and wall stress in post-MI HF after 1 week, accompanied by increased myocardial expression of markers of regulatory T cells. (v) Six weeks post-MI, there was an increase in markers of myocardial dysfunction and wall stress in CCR7 deficient mice.
CONCLUSIONS/SIGNIFICANCE: High serum levels of CCL21 are independently associated with mortality in chronic and acute post-MI HF. Our findings in CCR7 deficient mice may suggest that CCL21 is not only a marker, but also a mediator of myocardial failure. However, while short term inhibition of CCR7 may be beneficial following MI, a total lack of CCR7 during long-term follow-up could be harmful.
Arne Yndestad; Alexandra Vanessa Finsen; Thor Ueland; Cathrine Husberg; Christen P Dahl; Erik Øie; Leif Erik Vinge; Ivar Sjaastad; Øystein Sandanger; Trine Ranheim; Kenneth Dickstein; John Kjekshus; Jan Kristian Damås; Arnt E Fiane; Denise Hilfiker-Kleiner; Martin Lipp; Lars Gullestad; Geir Christensen; Pål Aukrust
Related Documents :
18984449 - Independent and incremental prognostic value of left ventricular ejection fraction dete...
6252299 - Tc-99m hmdp (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and ac...
9170439 - Effect of myocardial viability assessed by technetium-99m-sestamibi spect and fluorine-...
2344559 - Ischemic left ventricular dysfunction assessed on ecg-gated thallium-201 myocardial per...
8790039 - Assessment of myocardial viability with 99mtc sestamibi in patients undergoing cardiac ...
9310169 - Detection of impaired fatty acid metabolism in right ventricular hypertrophy: assessmen...
11499739 - Time course and determinants of left ventricular function recovery after primary angiop...
2662739 - Comparison of thrombolytic agents: selected hematologic, vascular and clinical events.
16670099 - Aspiration thrombectomy and primary percutaneous coronary intervention.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-03-12
Journal Detail:
Title:  PloS one     Volume:  7     ISSN:  1932-6203     ISO Abbreviation:  PLoS ONE     Publication Date:  2012  
Date Detail:
Created Date:  2012-03-19     Completed Date:  2012-08-20     Revised Date:  2013-06-26    
Medline Journal Info:
Nlm Unique ID:  101285081     Medline TA:  PLoS One     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e33038     Citation Subset:  IM    
Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Analysis of Variance
Chemokine CCL19 / blood
Chemokine CCL21 / blood*
Cross-Sectional Studies
Heart Failure / blood*,  etiology,  mortality,  physiopathology*
Immunoenzyme Techniques
Longitudinal Studies
Mice, Knockout
Middle Aged
Myocardial Infarction / blood*,  complications
Myocardium / metabolism
Real-Time Polymerase Chain Reaction
Receptors, CCR7 / blood,  genetics
Reg. No./Substance:
0/CCL19 protein, human; 0/CCL21 protein, human; 0/CCR7 protein, human; 0/Chemokine CCL19; 0/Chemokine CCL21; 0/Receptors, CCR7

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Analysis of microsatellite variation in Drosophila melanogaster with population-scale genome sequenc...
Next Document:  Carbon monoxide promotes respiratory hemoproteins iron reduction using peroxides as electron donors.